0 followers
OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.
Matthew Scholz
Thermo Fisher Scientific
179 followers
Genentech
161 followers
Gilead Sciences
136 followers
Regeneron
104 followers
Illumina
71 followers
Roivant Sciences
56 followers
Verily Life Sciences
38 followers
GRAIL
27 followers
Exact Sciences
18 followers
Charles River Laboratories
14 followers
Exelixis
13 followers
Explore companies